Paul Brunault1,2,3, Robert Courtois2,3, Ashley N Gearhardt4, Philippe Gaillard2,5,6,7, Kevin Journiac7, Sarah Cathelain3, Christian Réveillère3, Nicolas Ballon1,2,6,7. 1. 1 CHRU de Tours, Équipe de Liaison et de Soins en Addictologie, Tours, France. 2. 2 CHRU de Tours, Clinique Psychiatrique Universitaire, Tours, France. 3. 3 Département de Psychologie, Université François Rabelais de Tours, EA 2114 Psychologie des Âges de la Vie, Tours, Franc. 4. 4 Department of Psychology, University of Michigan, Ann Arbor, MI, USA. 5. 5 UMR INSERM U930 ERL, Tours, France. 6. 6 Université François Rabelais de Tours, Tours, France. 7. 7 Groupe Hospitalier Paul Guiraud, CSAPA Liberté, Bagneux, France.
Abstract
OBJECTIVE: The Yale Food Addiction Scale (YFAS) is the only questionnaire that assesses food addiction (FA) based on substance dependence criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM), Fourth Edition, Text Revision. Following recent updating of addiction criteria, a new DSM-5 version (YFAS 2.0) has been developed. Our study tested the psychometric properties of the French YFAS 2.0 in a nonclinical population. METHOD: We assessed 330 nonclinical participants for FA (French YFAS 2.0), eating behaviour, and eating disorder (Binge Eating Scale, Emotional Overeating Questionnaire, Three-Factor Eating Questionnaire-R18, Questionnaire on Eating and Weight Patterns-Revised, Eating Disorder Diagnostic Scale). We tested the scale's factor structure (confirmatory factor analysis based on 11 diagnostic criteria), internal consistency, and construct and incremental validity. RESULTS: Prevalence of FA was 8.2%. Our results supported a 1-factor structure similar to the US version. In both its diagnostic and symptom count versions, the YFAS 2.0 had good internal consistency (Kuder-Richardson alpha was 0.83) and was associated with body mass index (BMI), binge eating, uncontrolled and emotional eating, binge eating disorder, and cognitive restraint. FA predicted BMI above and beyond binge eating frequency. Females had a higher prevalence of FA than males but not more FA symptoms. CONCLUSIONS: We validated a psychometrically sound French version of the YFAS 2.0 in a nonclinical population, in both its symptom count and diagnostic versions. Future studies should investigate psychometric properties of this questionnaire in clinical populations potentially at risk for FA (that is, patients with obesity, diabetes, hypertension, or other metabolic syndrome risk factors).
OBJECTIVE: The Yale Food Addiction Scale (YFAS) is the only questionnaire that assesses food addiction (FA) based on substance dependence criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM), Fourth Edition, Text Revision. Following recent updating of addiction criteria, a new DSM-5 version (YFAS 2.0) has been developed. Our study tested the psychometric properties of the French YFAS 2.0 in a nonclinical population. METHOD: We assessed 330 nonclinical participants for FA (French YFAS 2.0), eating behaviour, and eating disorder (Binge Eating Scale, Emotional Overeating Questionnaire, Three-Factor Eating Questionnaire-R18, Questionnaire on Eating and Weight Patterns-Revised, Eating Disorder Diagnostic Scale). We tested the scale's factor structure (confirmatory factor analysis based on 11 diagnostic criteria), internal consistency, and construct and incremental validity. RESULTS: Prevalence of FA was 8.2%. Our results supported a 1-factor structure similar to the US version. In both its diagnostic and symptom count versions, the YFAS 2.0 had good internal consistency (Kuder-Richardson alpha was 0.83) and was associated with body mass index (BMI), binge eating, uncontrolled and emotional eating, binge eating disorder, and cognitive restraint. FA predicted BMI above and beyond binge eating frequency. Females had a higher prevalence of FA than males but not more FA symptoms. CONCLUSIONS: We validated a psychometrically sound French version of the YFAS 2.0 in a nonclinical population, in both its symptom count and diagnostic versions. Future studies should investigate psychometric properties of this questionnaire in clinical populations potentially at risk for FA (that is, patients with obesity, diabetes, hypertension, or other metabolic syndrome risk factors).
Authors: P Brunault; P Gaillard; N Ballon; C Couet; P Isnard; S Cook; I Delbachian; C Réveillère; R Courtois Journal: Encephale Date: 2016-03-24 Impact factor: 1.291
Authors: Susan M Mason; Alan J Flint; Andrea L Roberts; Jessica Agnew-Blais; Karestan C Koenen; Janet W Rich-Edwards Journal: JAMA Psychiatry Date: 2014-11 Impact factor: 21.596
Authors: Nathan A Gillespie; Michael C Neale; Carol A Prescott; Steven H Aggen; Kenneth S Kendler Journal: Addiction Date: 2007-06 Impact factor: 6.526
Authors: Sarah Cathelain; Paul Brunault; Nicolas Ballon; Christian Réveillère; Robert Courtois Journal: Presse Med Date: 2016-07-07 Impact factor: 1.228
Authors: Ashley A Wiedemann; Jessica L Lawson; Paige M Cunningham; Kathryn M Khalvati; Janet A Lydecker; Valentina Ivezaj; Carlos M Grilo Journal: Eur Eat Disord Rev Date: 2018-07-12
Authors: Emma T Schiestl; Julia M Rios; Lindsey Parnarouskis; Jenna R Cummings; Ashley N Gearhardt Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2020-10-28 Impact factor: 5.067
Authors: Roser Granero; Susana Jiménez-Murcia; Ashley N Gearhardt; Zaida Agüera; Neus Aymamí; Mónica Gómez-Peña; María Lozano-Madrid; Núria Mallorquí-Bagué; Gemma Mestre-Bach; Maria I Neto-Antao; Nadine Riesco; Isabel Sánchez; Trevor Steward; Carles Soriano-Mas; Cristina Vintró-Alcaraz; José M Menchón; Felipe F Casanueva; Carlos Diéguez; Fernando Fernández-Aranda Journal: Front Psychiatry Date: 2018-05-25 Impact factor: 4.157